Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rommel

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cell Reports|January 8, 2013
RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycleArito Yamane, Davide F Robbiani, Wolfgang Resch, et al.
Biochemical Society Transactions|March 30, 2004
Chemokine inhibition--why, when, where, which and how?Z Johnson, C A Power, C Weiss, et al.
Immunity|November 22, 2025
IL-9 signaling redirects CAR T cell fate toward CD8<sup>+</sup> memory and CD4<sup>+</sup> cycling states, enhancing antitumor efficacySofía Castelli, Wesley V Wilson, Ugur Uslu, et al.
Cell|August 16, 2015
Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell LymphomaDavide F Robbiani, Stephanie Deroubaix, Niklas Feldhahn, et al.
Journal for Immunotherapy of Cancer|January 9, 2026
Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitationsPhilipp C Rommel, Nils W Engel, Julia K Malachowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.
Leukemia|October 24, 2012
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemiaM R Janes, C Vu, S Mallya, et al.
The Journal of Experimental Medicine|December 21, 2012
Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switchingAnne Bothmer, Philipp C Rommel, Anna Gazumyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cell Reports|January 8, 2013
RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycleArito Yamane, Davide F Robbiani, Wolfgang Resch, et al.
Biochemical Society Transactions|March 30, 2004
Chemokine inhibition--why, when, where, which and how?Z Johnson, C A Power, C Weiss, et al.
Immunity|November 22, 2025
IL-9 signaling redirects CAR T cell fate toward CD8<sup>+</sup> memory and CD4<sup>+</sup> cycling states, enhancing antitumor efficacySofía Castelli, Wesley V Wilson, Ugur Uslu, et al.
Cell|August 16, 2015
Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell LymphomaDavide F Robbiani, Stephanie Deroubaix, Niklas Feldhahn, et al.
Journal for Immunotherapy of Cancer|January 9, 2026
Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitationsPhilipp C Rommel, Nils W Engel, Julia K Malachowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.
Leukemia|October 24, 2012
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemiaM R Janes, C Vu, S Mallya, et al.
The Journal of Experimental Medicine|December 21, 2012
Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switchingAnne Bothmer, Philipp C Rommel, Anna Gazumyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.
Cell|June 25, 2026
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapyDaniel J Baker, Leon M Frommer, Ugur Uslu, et al.
Pageof 5